| Literature DB >> 19855425 |
Meredith J Aull, Manikkam Suthanthiran.
Abstract
Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19855425 DOI： 10.1038/nrneph.2009.164
Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314